Syros Pharmaceuticals Inc.

Market cap: $48,829,100

Exchange: NAS

Sector: Health Technology

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Key Statistics

Company Name

Syros Pharmaceuticals Inc.

Average Volume (10 days)

286,302

Average Volume (30 days)

194,302

Moving Average (50 days)

$7.11

Moving Average (200 days)

$4.69

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-1.5555

Market Cap

48,829,100

Shares Outstanding

6,300,529

52-Week High Split Adjust Only

8.17

52-Week Low Split Adjust Only

2.09

Employee Count

132

Beta

0.3402

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.07%

Past 30 days

0.01%

Past 3 months

1.91%

Past 6 months

1%

Past year

1.06%

Past 2 years

-0.41%

Past 5 years

-0.89%

Max % Change

-0.96%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Syros Pharmaceuticals Inc.SYRS22.752.66-4.422.7512.38
Peer AvgN/An/an/a-13.3n/an/a
Ocular Therapeutix IncOCULn/an/a-19.1n/an/a
Olema Pharmaceuticals IncOLMAn/an/a-21.2n/an/a
Oncocyte CorporationOCXn/an/a-13.1n/an/a
Oragenics Inc.OGENn/an/an/an/an/a